Apyx Medical Stock Performance
| APYX Stock | USD 1.50 0.18 13.64% |
The firm shows a Beta (market volatility) of 1.56, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Apyx Medical will likely underperform. Apyx Medical has an expected return of -0.4%. Please make sure to confirm Apyx Medical value at risk and rate of daily change , to decide if Apyx Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Apyx Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Purchase by Renn Universal Growth Investment Trust of 7100 shares of Apyx Medical | 02/26/2024 |
2 | Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024 | 03/04/2024 |
3 | Acquisition by Charles Goodwin of 9750 shares of Apyx Medical at 5.97 subject to Rule 16b-3 | 03/15/2024 |
4 | Apyx Medical Reports Q4 Loss, Tops Revenue Estimates | 03/21/2024 |
5 | Apyx Medical Insiders Lose Out As Stock Sinks To US1.32 | 03/22/2024 |
6 | Acquisition by John Andres of 17000 shares of Apyx Medical at 9.42 subject to Rule 16b-3 | 03/26/2024 |
7 | Disposition of 8000 shares by Lawrence Waldman of Apyx Medical subject to Rule 16b-3 | 03/28/2024 |
8 | Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion Users Summit | 04/11/2024 |
9 | Revenues Working Against Apyx Medical Corporations Share Price Following 25 percent Dive | 04/18/2024 |
| Begin Period Cash Flow | 10.2 M |
Apyx |
Apyx Medical Relative Risk vs. Return Landscape
If you would invest 227.00 in Apyx Medical on January 26, 2024 and sell it today you would lose (77.00) from holding Apyx Medical or give up 33.92% of portfolio value over 90 days. Apyx Medical is currently does not generate positive expected returns and assumes 7.1613% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than Apyx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Apyx Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Apyx Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Apyx Medical, and traders can use it to determine the average amount a Apyx Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0559
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | APYX |
Estimated Market Risk
| 7.16 actual daily | 63 63% of assets are less volatile |
Expected Return
| -0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Apyx Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Apyx Medical by adding Apyx Medical to a well-diversified portfolio.
Apyx Medical Fundamentals Growth
Apyx Stock prices reflect investors' perceptions of the future prospects and financial health of Apyx Medical, and Apyx Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Apyx Stock performance.
| Return On Equity | -0.58 | ||||
| Return On Asset | -0.19 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.39) % | ||||
| Current Valuation | 40.8 M | ||||
| Shares Outstanding | 34.64 M | ||||
| Price To Earning | 4.04 X | ||||
| Price To Book | 1.84 X | ||||
| Price To Sales | 0.97 X | ||||
| Revenue | 52.35 M | ||||
| Gross Profit | 29.13 M | ||||
| EBITDA | (19.26 M) | ||||
| Net Income | (18.71 M) | ||||
| Cash And Equivalents | 20.06 M | ||||
| Cash Per Share | 0.58 X | ||||
| Total Debt | 38.5 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 4.45 X | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | (5.25 M) | ||||
| Earnings Per Share | (0.54) X | ||||
| Market Capitalization | 45.73 M | ||||
| Total Asset | 79.24 M | ||||
| Retained Earnings | (54.45 M) | ||||
| Working Capital | 57.62 M | ||||
| Current Asset | 10.01 M | ||||
| Current Liabilities | 2.45 M | ||||
About Apyx Medical Performance
To evaluate Apyx Medical Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Apyx Medical generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Apyx Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Apyx Medical market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Apyx's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 94.75 | 112.93 | |
| Return On Tangible Assets | (0.24) | (0.22) | |
| Return On Capital Employed | (0.30) | (0.29) | |
| Return On Assets | (0.24) | (0.22) | |
| Return On Equity | (0.70) | (0.67) |
Things to note about Apyx Medical performance evaluation
Checking the ongoing alerts about Apyx Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Apyx Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Apyx Medical generated a negative expected return over the last 90 days | |
| Apyx Medical has high historical volatility and very poor performance | |
| Apyx Medical may become a speculative penny stock | |
| The company reported the previous year's revenue of 52.35 M. Net Loss for the year was (18.71 M) with profit before overhead, payroll, taxes, and interest of 29.13 M. | |
| Apyx Medical currently holds about 20.06 M in cash with (5.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| Roughly 18.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Revenues Working Against Apyx Medical Corporations Share Price Following 25 percent Dive |
- Analyzing Apyx Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Apyx Medical's stock is overvalued or undervalued compared to its peers.
- Examining Apyx Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Apyx Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Apyx Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Apyx Medical's stock. These opinions can provide insight into Apyx Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for Apyx Stock analysis
When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Apyx Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Apyx Medical. If investors know Apyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Apyx Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.512 | Quarterly Revenue Growth 0.163 | Return On Assets (0.19) | Return On Equity (0.58) |
The market value of Apyx Medical is measured differently than its book value, which is the value of Apyx that is recorded on the company's balance sheet. Investors also form their own opinion of Apyx Medical's value that differs from its market value or its book value, called intrinsic value, which is Apyx Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Apyx Medical's market value can be influenced by many factors that don't directly affect Apyx Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Apyx Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Apyx Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Apyx Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.